Name | (S)-Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate |
---|---|
Synonyms |
Valsartan benzyl ester
L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester Benzyl N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valinate benzyl (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate T5MNNNJ ER BR D1NV4&YVO1R&Y1&1 &&L or S Form Phenylmethyl N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valinate Benzyl N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valinate Benzyl N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valinate Valsartan Impurity 2 |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 720.1±70.0 °C at 760 mmHg |
Melting Point | >71° C(dec.) |
Molecular Formula | C31H35N5O3 |
Molecular Weight | 525.641 |
Flash Point | 389.3±35.7 °C |
Exact Mass | 525.273987 |
PSA | 101.07000 |
LogP | 7.16 |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.589 |
Hazard Codes | Xn |
---|
~90% 137863-20-8 |
Literature: ENANTIA, S. L. Patent: WO2006/67216 A2, 2006 ; Location in patent: Page/Page column 29 ; WO 2006/067216 A2 |
~% 137863-20-8 |
Literature: WO2005/49588 A1, ; Page/Page column 6 ; |
~% 137863-20-8 |
Literature: WO2004/26847 A1, ; Page 26; 32-33 ; WO 2004/026847 A1 |
~0% 137863-20-8 |
Literature: ZENTIVA, a.s. Patent: WO2005/21535 A2, 2005 ; Location in patent: Page/Page column 15 ; |
~% 137863-20-8 |
Literature: Organic Process Research and Development, , vol. 15, # 5 p. 986 - 988 |
Precursor 5 | |
---|---|
DownStream 1 | |